Interventional Cardiology Research at the University of Maryland is designed to provide the most technologically advanced treatment for patients, which meshes with institution's desire to be at the forefront of medical research.
Cardiology fellows are to be aware of all on-going studies and are to consider each patient for an appropriate study. The fellows are expected to be HIPPA compliant and IRB trained. The IRB has a web-based training for all staff involved with research to complete the "Protecting Human Research Subjects" training.
Various studies include the focus of acute myocardial infarction, unstable and/or stable angina, IVUS, new devices (radiation, sonotherapy, stents, PFO, etc.), genetics, drug therapy (IIb/IIIa, contrast agents, etc.) and registries. The focus of some trials may incorporate other disease processes, such as renal and diabetes, with cardiac and to evaluate patient outcomes.